Awarded the Nobel Prize in 2020, Emmanuelle Charpentier’s ground-breaking work on CRISPR/CAS9 irrevocably changed the genetics landscape. Emmanuelle co-founded ERS Genomics to enable the global life science community to access and benefit from this new technology.
Born in France, Emmanuelle is a microbiologist, geneticist and biochemist. Emmanuelle received her Ph.D from the University Pierre and Marie Curie in Paris, for research performed at the Pasteur Institute. Beyond Paris, Emmanuelle has made scientific contributions in academic institutions across the globe.
Currently at the Max Planck Unit for the Science of Pathogens in Berlin, Emmanuelle has also worked in Paris, New York, Memphis,
Vienna, Umeåand Braunschweig.
She has received numerous prestigious national and international awards and distinctions and is an elected member of national and international academies.